Verax Biomedical

Verax Biomedical develops rapid tests for the detection of bacterial contaminants in cellular components for transfusion or transplant.

Verax Biomedical was founded upon the singular vision of detecting bacterial contamination in cells and tissues intended for transfusion and transplantation. Recognizing that bacteria pose a unique infectious challenge in these life giving tissues, they realized that novel approaches to detection were called for. While these cellular materials are routinely tested for viral contaminants, bacteria have posed a long standing and heretofore poorly addressed challenge. Unlike viruses, bacteria can replicate outside of a living host, meaning they can grow in these cellular matrices during storage prior to transfusion or transplantation. This results in the unique dilemma of an infectious contaminant that can grow from unmeasurably low levels at the time of collection to massive levels at the time of transfusion or transplantation, posing a serious and often fatal risk to their recipient.